A cancer-associated aurora A mutant is mislocalized and misregulated due to loss of interaction with TPX2

Rachel Ann Bibby1, Chan Tang, Amir Faisal

  • 1Section of Structural Biology, The Institute of Cancer Research, Chester Beatty Laboratories, UK.

Insights

Somatic mutations in Aurora A kinase alter its activity, potentially driving cancer. The S155R mutation disrupts TPX2 interaction, leading to chromosomal abnormalities and possibly promoting aneuploidy in colon cancer.

Area of Science:

  • Molecular Biology
  • Cancer Genetics
  • Structural Biology

Background:

  • Protein kinases, including Aurora A, are crucial in cell division and cancer development.
  • Somatic mutations in Aurora A kinase can alter its function and contribute to tumorigenesis.
  • The specific impact of cancer-associated Aurora A mutations on kinase activity and regulation remains largely undetermined.

Purpose of the Study:

  • To investigate the functional consequences of three somatic cancer-associated mutations in the catalytic domain of Aurora A kinase.
  • To characterize the Aurora A(S155R) mutant, focusing on its interaction with TPX2 and structural basis of disruption.
  • To explore the potential role of Aurora A mutations in microsatellite instability-positive colon cancer.

Main Methods:

  • Analysis of kinase activity for three Aurora A mutants (V174M, S155R, S361*).
  • Biochemical and structural characterization of the Aurora A(S155R) mutant, including interaction studies with TPX2 and X-ray crystallography.
  • Screening of colon cancer patient samples for the presence of Aurora A mutations.

Main Results:

  • Aurora A(V174M) exhibited constitutively increased kinase activity.
  • Aurora A(S155R) showed decreased activity due to misregulation, linked to loss of TPX2 interaction.
  • Aurora A(S361*) activity was ablated due to loss of structural integrity.
  • Structural analysis of Aurora A(S155R) revealed disruption of TPX2 binding at 2.5 Å resolution.
  • One microsatellite instability-positive colon cancer patient sample showed exclusive presence of Aurora A(S155R) in tumor tissue.

Conclusions:

  • Somatic mutations in Aurora A kinase can lead to distinct alterations in kinase activity and regulation, suggesting diverse roles in cancer.
  • The S155R mutation impairs Aurora A function by disrupting its interaction with TPX2, potentially causing chromosomal abnormalities and aneuploidy.
  • The S155R mutation represents a potential, albeit infrequent, driver of aneuploidy in microsatellite instability-positive colon cancer through dysregulated protein interactions.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...